Clinical Evaluation of Palingu abraga parpam in The Management of Diabetes Mellitus (Niddm)
|
|
- Kenneth Marsh
- 6 years ago
- Views:
Transcription
1 Original Article Bulletin of Environment, Pharmacology and Life Sciences Online ISSN Bull. Env. Pharmacol. Life Scien. Volume 1 [12] November 2012: , Academy for Environment and Life Sciences, India Website: Clinical Evaluation of Palingu abraga parpam in The Management of Diabetes Mellitus (Niddm) Anbu N 1 *, Md Musthafa M 1, Pitchiah Kumar M 2 and Velpandian V 2 1 Department of Maruthuvam (Medicine), Government Siddha Medical College, Chennai , Tamilnadu, India. 2 Department of Gunapadam (Pharmacology), Government Siddha Medical College, Chennai , Tamilnadu, India. nanbu.sumi@gmail.com ABSTRACT Diabetes mellitus is one of the metabolic disorders prevalent worldwide and causes increase in the blood glucose level due to insufficient insulin secretion. Due to this peripheral utilization of glucose is reduced, which in turn disturbs the basic metabolism. Diabetes mellitus is categorized into Type I or Insulin dependent diabetes mellitus (IDDM) and Type II or Non- Insulin dependent diabetes mellitus (NIDDM). Complete destruction of islets of Langerhan's leads to sole dependence of insulin for the metabolic requirements in Type I diabetic patients, whereas relative insufficiency of insulin in Type II DM can be managed by oral hypoglycemic drugs. Palingu Abraga Parpam is one of the herbo-mineral based Siddha anti diabetic formulation for Type II non insulin dependent diabetes mellitus. So the present research work was carried out to validate the anti diabetic activity of Palingu Abraga Parpam clinically on patients with Type II diabetes mellitus. Open clinical trial was conducted in 75 diabetic patients for the period of six months. Fasting and post prandial serum blood glucose level and HbA1c were estimated before the enrollment of the study, during the trial period and after the completion of the study. At the end of the study period all these parameters were statistically analyzed. The clinical studies revealed that Palingu Abraga Parpam was highly significant in NIDDM (Blood sugar level varies from 180 to 300 mg / dl). The blood sugar level was controlled effectively within 4 weeks, when compared to its initial blood sugar level. Whereas HbA1c was decreased to its normal reference range within 3 months. During the study period there was no side effects identified and which confirms the traditional use of Palingu Abraga Parpam (PAP) for the treatment of Type II diabetes mellitus. KEY WORDS: Anti diabetic activity, diabetes mellitus, FBGL, HbA1c, insulin, Palingu Abraga Parpam (PAP), PPBGL, Type II NIDDM. INTRODUCTION Diabetes is one of the ancient diseases. The history of diabetes is stated that in the Ebers papyrus (1500 BC) [1]. Polyuria and honey urine was noted as early as 400 BC by the Indian Physician Susrutha and he has described this disease as Madhumeham which means the honey in the urine [2]. Type II Diabetes mellitus is a metabolic disorder due to deficiency of insulin leads to hypoglycaemia which is characterized by polyuria, polyphagia, and polydipsia. Diabetes mellitus is one of the metabolic endocrine disorder that affects more than 200 million people worldwide and 300 million will have the disease diabetes mellitus by 2025 [3-5]. If it is not controlled by medicine it will affect most of the internal organs and produce short term and long term complications like nephropathy, neuropathy, retinopathy etc. [6] Though numerous anti diabetic drugs available in day today practice either have a source directly or indirectly from the nature. According the ethnobotanical information report, nearly 800 plants used to treat the diabetes mellitus and said to possess anti diabetic property [7]. In the past decade, research has been focused on scientific evaluation of traditional drugs of herbal and mineral origin were screening of more effective and safe hypoglycemic agents has continued to be an important area of present day research[8]. In developing countries 80 % of population is using traditional medicine in primary medical problems [9]. In the present study, an attempt has been made to investigate the anti-diabetic activity of Palingu Abraga Parpam (PAP) in Type II NIDDM patients clinically. Palingu Abraga Parpam is a herbo-mineral formulation and this is well known for its anti diabetic activity in the traditional Siddha system of medicine from time immortal for their various therapeutic properties especially hypoglycemic activity [10]. BEPLS Vol 1 [12] 2012 ~ 37 ~ AELS, INDIA
2 MATERIALS AND METHODS The Open clinical trial was conducted at Arignar Anna Government Hospital of Indian Medicine, Chennai from January 2012 to June The protocol of this clinical study was approved by the Institutional Ethical Committee and conducted according to the guidelines of the Declaration of Helsinki [11]. A written informed consent in both English and Tamil was obtained before the enrollment of the patients. Total number of 75 cases of either sex irrespective of socio economic status was selected for this clinical trial from OPD and IPD in the department of medicine. The patients registered in the study showed the baseline characteristics of age ranging from 35 years of age to 65 years. They were all under the medical care on direct supervision by the author. Selection Criteria Patients selected for this study were based on inclusion criteria and exclusion criteria. Inclusion criteria for the patients with confirmed diagnosis of type 2 diabetes, patients of either sex between the age of years, patients with FBGL 140 mg/dl and PPBGL 240 mg/dl[12-13] were included. American Diabetes Association Standards of Medical Care in Diabetes recently added the HbA1c 48 mmol/mol ( 6.5%) as another criterion for the diagnosis of diabetes [14]. Hence, HbA1c 7 criteria was also included in the present study. Patients more than 65 years and less than 35 years, inter current treatment for major or other chronic health conditions like gastro intestinal disturbances, liver disorders, cardiac involvements, hypertension, kidney disorders and endocrine disorder other than diabetes mellitus, Type I DM, AIDS, STD, pregnancy, lactation, habits of alcohol intake and smoking were identified and excluded from the study. Proper history taking and clinical assessment were done including the estimation of fasting blood glucose level (FBGL), Post Prandial Blood Glucose Level (PPBGL) and HbA1c at the time of enrollment, during the visits and at the end of the study. Statistical comparison of the initial and final readings were analyzed and recorded. Study Design All the patients enrolled in the present study were divided into three groups. Group I (n=25) : Diabetic standard group. In this group all the diabetic patients were treated with standard oral hypoglycemic drugs which were prescribed by the primary physicians. Group II (n=25) : In this group all the diabetic patients were treated with PAP 100 mg twice a day with hot water. Group III (n=25) : In this group all the diabetic patients were treated with PAP 100 mg twice a day with hot water and oral hypoglycemic drugs of their own. Formulation of the trial drug The mineral formulation of Palingu Abraga Parpam described in Anuboga Vaithiya Navaneetham Part-2 [10] Ingredients of the drug According to Siddha classical text, the ingredients of Palingu Abraga Parpam (PAP) are Mica (White Abragam), common oyster shell, Potassium nitrate (Vediyuppu) and the plant Eclipta alba (Karisalai). The raw materials were collected from country drug shop at Chennai and the plant Eclipta alba (Karisalai) was collected in and around Chennai. The entire raw materials and plant were identified and authenticated by the Gunapadam (Pharmacology) experts and by the botanist of Government Siddha Medical College, Chennai. The vouchers specimens of each sample of the raw materials and plant were kept in the department for future reference. Each raw material were cleaned and purified separately as per the Siddha text. For the purification of mica, the following Suddhi (Purification process) was adopted. The Eclipta alba (Karisalai) cleaned well with water and grind to get juice. 70 gm of mica rake was taken and immersed with 700 gm Eclipta alba (Karisalai) juice which was kept under the shade for drying. After complete drying, mica was taken for further process. A small pit having a measurement of 2 x 2 x 2 feet was made and the mica was placed in the pit between the 100 cow dung cakes (Varatties) and fired. The next day the mica was taken and allowed for cooling which was placed in a glass jar. This is the purification method of mica (white Abragam). Then crucible was taken and filled partially with unhydroxylated common oyster shell and potassium nitrate (Vediyuppu) respectively. Then the purified mica (white Abragam) was kept above the two layers in the center. The same process of filling with unhydroxylated common oyster shell and potassium nitrate respectively were applied once again BEPLS Vol 1 [12] 2012 ~ 38 ~ AELS, INDIA
3 above the mica (white Abragam). Then the crucible was sealed with seven layers of mud cloth (Seelai man) and allowed for drying. After drying the crucible kept in another 5 x 5 x 5 feet pit for Pudam (calcinations process) with 1000 cow dung cakes and ignited. After 24 hours, the crucible was taken out and allowed for cooling. Then the drug was taken away from the crucible and powdered well. Good manufacturing practice was followed during the preparation. Then the prepared drug was kept in an air tight container and labeled as PAP. Dosage and Advise: The drug PAP was given to the patients at the dose of 100 mg twice a day with hot water. All the patients were advised to avoid direct sugar, underground root vegetables and advised to take plenty of leafy and fiber vegetables. Laboratory Investigations All the patients enrolled in the study were subjected to the following laboratory investigations which include the biochemical analysis of initial FBGL, PPBGL and HbA1c. Blood samples were obtained from each patient prior to, during and after administration of Palingu Abraga Parpam (PAP). About 3 cc of blood was obtained from each patient through vene-puncture by using disposable sterile syringes for FBGL, PPBGL and HbA1c which were investigated in nearby laboratories and at the hospital of confinement. Statistical Analysis The above data of pre and post treatment were analyzed statistically by Student s Paired t - test. P value was considered statistically highly significant and P value was considered as extremely significant which were shown in Table No. 3. RESULTS AND DISCUSSION The six months period of open labeled clinical study was performed to evaluate the efficacy of PAP in patients with Type II NIDDM. A total number of 75 patients were participated in the present study, in which 40 were men and 35 were women with in the age range of years (Table No.1). Out of 75 patients, 65 patients were treated as out-patients and 10 patients who were very sick and were hospitalized. During the trial period no drop outs were recorded. The baseline clinical features of the enrolled subjects were summarized in Table No.2. After baseline evaluation, these patients were divided into three groups. Standard group (Group I) was treated with modern oral hypoglycaemic drugs prescribed by the primary physician. Second group (Group II) was treated with PAP 100 mg twice a day with hot water and third group (Group III) was treated with PAP 100 mg twice a day with hot water combined with their own oral hypoglycaemic drugs. The signs and symptoms such as polyuria, polyphagia, polydipsia, general weakness and body pain of all groups were noted separately and recorded at initial visit, each weekly visit and at the end of the study. After 4 weeks of trial period, there was a gradual improvement in the clinical features were observed in all the three groups. However, the signs and symptoms were more markedly observed in the group III. The result of the clinical features and improvement status were summarized in Table No.2. FBGL, PPBGL and HbA1c level of all the three groups were regularly monitored and recorded from the initial period to end of the study period with weekly interval and the statistical analysis between pre test and post test was summarized in Table No.3. The initial FBGL value (Mean ± SD) of group I, II and III were ±5.24, ±3.65 and ±3.92 respectively. After three months of treatment FBGL value (Mean ± SD) were ±3.40, ±4.36 and ±2.26 respectively (Fig.No.1). The initial PPBGL (Mean ± SD) of group I, II and III were ±4.55, ±3.45, and ±4.46 respectively. After completion of the trial the PPBGL (Mean ± SD) were ±3.47, ±3.27 and ±2.73 which was shown in Fig No.2. The initial level of HbA1c of groups I, II and III were 8.17±0.25, 7.99±0.14 and 8.02±0.19 and after treatment the level of HbA1C were 6.59±0.18, 7.10±0.15 and 6.35±0.12 respectively which was shown in Fig No.3. Significant decrease in FBGL, PPBGL and HbA1c were observed in all the three groups and maintained better control of their blood sugar levels during the follow up period. Fall in blood sugar level in group II was found to be highly significant and nearer to the standard drug group which confirmed the hypoglycaemic effect of PAP. The patients of group III receiving PAP and standard hypoglyceamic drug showed extremely significant reduction in FBGL, PPBGL and HbA1c value when compared with group I and II and gradually reached to normal level at the end of one BEPLS Vol 1 [12] 2012 ~ 39 ~ AELS, INDIA
4 month and maintained during the follow-ups without notable fluctuations which was confirmed the synergistic effect of the combination of trial drug PAP and modern standard drug. During the study period no side effect was observed. In this clinical study the diabetic patients were participated actively in the management of sugar level along with life style modifications and they were developed their confidence level successfully. HbA1c is an important marker for better glycaemic control therapy. In this present study HbA1c levels in Group I, II and III decreased within the reference range confirmed the hypoglycemic effect of standard drug and the trial drug PAP. Mica (Abragam) was used traditionally in the management of Type II diabetes mellitus patients in Siddha system of medicine and the anti diabetic activity of Abragam was scientifically confirmed by preclinical research works [15]. The result of this clinical study also provides the successful proof of the traditional practice and preclinical research work of PAP. Table No.1 Showing Age and Sex distribution Category yrs yrs yrs yrs Type 2 DM ( n= 75) Male: 12 Female: 10 Male: 14 Female: 16 Male: 10 Female: 6 Male: 04 Female: 03 Table No.2 Showing the signs and symptoms of Type 2 DM patients and showing the clinical improvement at the end of the study Clinical features Group I (n=25) Group II (n=25) Group III (n=25) BT AT % of Imp BT AT % of Imp BT AT % of Imp Polyuria Polydipsia Polyphagia General weakness Itching Body pain BT - Before Treatment, AT - After Treatment, % of Imp - Percentage of improvement Table No. 3: Showing the efficacy of Palingu Abraga Parpam on FBGL, PPBGL and HbA1c in treated patients Group (n = 25) Fasting glucose (mg/dl) Post Prandial (mg/dl) HbA1C (mg %) BT AT BT AT BT AT Standard drug PAP 100 mg Standard drug + PAP 100mg ±5, ± ± ±3.40*** ±4.36** ±2.26*** ± ± ± ±3.47*** ±3.27** ±2.73*** 8.17± ± ± ±0.18* 7.10±0.15* 6.35±0.12** BEPLS Vol 1 [12] 2012 ~ 40 ~ AELS, INDIA
5 mg / dl Fig No.1. Showing FBGL Standard PAP 100 Standard + PAP 100 GROUPS BT AT mg / dl Fig No. 2. Showing PPBGL Standard PAP 100 Standard + PAP 100 GROUPS BT AT mg % Fig No. 3. Showing HbA1C Standard PAP 100 Standard + PAP 100 GROUPS BT AT BEPLS Vol 1 [12] 2012 ~ 41 ~ AELS, INDIA
6 CONCLUSION From this above study the test drug PAP is highly significant in Type II NIDDM patients which are confirmed by the statistical analysis. All the patients were gradually improved their signs and symptoms and reduction of FBGL, PPBGL and HbA1C values over the period of three months. The trial drug PAP lowers the fasting blood glucose level, post prandial blood glucose level and provide the reference range of HbA1C level. No untoward or side effects were noted during the study period. The clinical study revealed that the herbo-mineral drug PAP was well tolerated in dose of 100 mg twice a day with hot water and was effective in type II diabetes mellitus as indicated by reduction in blood sugar levels after 4 weeks. The hypoglycaemic effect of PAP may be due to the increase in the utilization of peripheral metabolism of glucose or by increased insulin secretion from beta cells of pancreas [16]. From this study we concluded that the trial drug PAP may be administered as alternative drug for diabetic treatment or combined with standard oral hypoglycaemic drug for uncontrolled diabetes mellitus and maintain the blood glucose level with in the normal range which favors the prevention of diabetic complications. ACKNOWLEDGEMENT The authors are grateful to the Principal, Government Siddha Medical College, Chennai 106 and the Head of the department of Maruthuvam (Medicine) and Gunapadam (Pharmacology), Government Siddha Medical College, Chennai for their valuable guidance and constant support during the study period. REFERENCES 1. Kathryn M Kiag, Greg Rubin. British Journal of Nursing, Vol.12, issue Charaka Samhita Vol II. Chikitsasthana. P.V. Sharma. (1983).Chaukhamba Orientalia, Varanasi (India); Amos A, McCarty D, Zimmet P. (1997) The rising global burden of diabetes and its complications, estimates and projections to the year Diabetic Med ; 14: S1- S King H, Aubert R, Herman W. (1998). Global burden of diabetes, Prevalence, numerical estimates and projections. Diabetes Care; 21: Zimmet P. (2000). Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Med; 247: Edwards CRW, Boucheir IAD, Haslett C, Chilvers ER. (1995).Davidson s Principles and Practice of Medicine. British Library Cataloguing in Publication Data Seventeenth edition; Wild S, Roglic G, Green A, Sicree R, King H. (2004). Global prevalence of diabetes. Estimates for the year 2000 and projections for Diabetes Care; 27: Jackson J E, Breasler R;(1981). Clinical pharmacology of sulfonylurea hypoglycemic agents Part I. Drugs.; 22: Alarcon-Aguilara, F.J., R.Roman-Ramas,S.Peroz Gutierrez, A.Aguilator-Contreras, C.C.Conteras Weber and J.L.Flores Saenz,(1998). Study of anti-hyperglycemic effect of Plants used as anti-diabetics. J.E.Ethnopharmacol, 61: Hakkim Abdulla Sahibu. Anuboga Vaithiya Navaneetham, Part 2, Thamarai publications, September (1995): World Medical Association. (1997).Declaration at Helsinki. Recommendations guiding physicians in biochemical research involving human subjects. Cardiovasc.Res.; 35: WHO, (1992). Diabetes Mellitus, report of study group, Geneva WHO technical report series: Nobert W Tielt. (1976), Fundamentals of clinical chemistry, Philadelphia: W.B.Saunders company 2nd ed, 14. Executive summary: Standards of medical care in diabetes (2010). Diabetes Care 33 (Suppl1): S4 10. January Date of issue: /dc10-S004. PMC PMID Banani D, Achintya M, Hazra J, (2011). Management of madhumeha (diabetes mellitus) with current evidence and intervention with ayurvedic rasaushadhies, Indian Journal of Traditional Knowledge,; 10(4); (Abraga Parpam) 16. T.B.Ng, C.M.Wong,W.W.Li and H.W.Yeung, J.Ethnopharmacol., 15 (1), 107. (1986). BEPLS Vol 1 [12] 2012 ~ 42 ~ AELS, INDIA
Introduction 1 CHAPTER I INTRODUCTION
Introduction 1 CHAPTER I INTRODUCTION World Health Organisation (W.H.O.) projected an increase of diabetes which has already reached epidemic proportions, particularly in urban India. Possibly by the year
More informationEfficacy of Vamana followed by Nyagrodadi Churna in the management of sthula madhumeha (NIDDM)
ANALYSIS 21(87), September - October, 2017 ISSN 2321 7359 EISSN 2321 7367 Medical Science Efficacy of Vamana followed by Nyagrodadi Churna in the management of sthula madhumeha (NIDDM) Meera KJ 1, Pujar
More informationInt J Ayu Pharm Chem. e-issn
RESEARCH ARTICLE www.ijapc.com e-issn 2350-0204 Clinical Study of Lotus (Nelumbonuciferagaertn) Rhizome as a Hypoglycemic agent in the Management of Type-2 Diabetes mellitus Nazma Ahmed 1 * and Bishnu
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationEFFICACY OF NUTRACEUTICALS ON BLOOD GLUCOSE AND LIPID PROFILE AMONG SOUTH INDIAN TYPE 2 DIABETIC POPULATION
EFFICACY OF NUTRACEUTICALS ON BLOOD GLUCOSE AND LIPID PROFILE AMONG SOUTH INDIAN TYPE 2 DIABETIC POPULATION Dr.P.NAZNI, M.Sc.,M.Phil., Ph.D Lecturer, Department of Food Science, Periyar University, Salem
More informationAwareness and Prevalence of Diabetes Mellitus Among Housewives in Baneshwar of Nepal
Original article: Awareness and Prevalence of Diabetes Mellitus Among Housewives in Baneshwar of Nepal *Kharel Sushil 1, Mainalee Mandira 2 1Lecturer, Department of Physiology, Kathmandu Medical College
More informationIndian Pharmaceutical Association Indian Pharmaceutical Association
55 th National Pharmacy Week November 20 th to 26 th 2016 Theme Pharmacists for a Healthy India: Role in Prevention and Management of Diabetes Indian Pharmaceutical Association www.ipapharma.org Indian
More informationCombining Complex Pathophysiologic Concepts: Diabetes Mellitus
Chapter 18 Combining Complex Pathophysiologic Concepts: Diabetes Mellitus KEY TERMS dawn phenomenon diabetes mellitus endocrine pancreas exocrine pancreas hyperglycemia hyperketonemia hypoglycemia insulin
More informationDiabetes. HED\ED:NS-BL 037-3rd
Diabetes HED\ED:NS-BL 037-3rd Diabetes Diabetes mellitus is an epidemic disease and based on a recent study published on 2011, the estimated number of affected people is 366 million worldwide and the number
More informationEffect of Transcutaneous Electrical Nerve Stimulation on Acupoints in Type 2 Diabetes Mellitus A Blood Glucose Analysis
EUROPEAN ACADEMIC RESEARCH Vol. II, Issue 1/ April 2014 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.1 (UIF) DRJI Value: 5.9 (B+) Effect of Transcutaneous Electrical Nerve Stimulation on Acupoints
More informationDiabetes Mellitus Aeromedical Considerations. Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013
Diabetes Mellitus Aeromedical Considerations Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013 Metabolic, Nutritional or Endocrine disorders Applicants with metabolic, nutritional
More informationNHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes
Guidelines for the Diagnosis of Diabetes Mellitus NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Lead Authors: Dr Brian Kennon, Dr David Carty June 2015 Review due: December 2016 Diagnosis
More informationWhy do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?
What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action
More informationKeywords: glycosylated haemoglobin, plasma glucose, correlation.
: C Microbiology and Pathology Volume 15 Issue 1 Version 1.0 Year 2015 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print
More informationCARBOHYDRATE METABOLISM Disorders
CARBOHYDRATE METABOLISM Disorders molecular formula C12H22O11 Major index which describes metabolism of carbohydrates, is a sugar level in blood. In healthy people it is 4,4-6,6 mmol/l (70-110 mg/dl)
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Thu, 23 Aug 2018 03:29:00 GMT) CTRI Number Last Modified On 05/11/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationCLINICAL PROFILE OF TYPE 2 DIABETIC PATIENTS IN A TERTIARY CARE HOSPITAL IN COASTAL KARNATAKA
CLINICAL PROFILE OF TYPE 2 DIABETIC PATIENTS IN A TERTIARY CARE HOSPITAL IN COASTAL KARNATAKA * Sanjay Kini and Avinash Kumar Department of Community Medicine, Kasturba Medical college, Manipal *Author
More informationDiabetes in the Elderly 1, 2, 3
Diabetes in the Elderly 1, 2, 3 WF Mollentze Feb 2010 Diabetes in the elderly differs from diabetes in younger people Prevalence: o Diabetes increases with age affecting approximately 10% of people over
More informationAN ORDINARY DIFFERENTIAL EQUATION MODEL OF DIABETIC POPULATION IN NEW DELHI
Indian Journal of Mathematics and Mathematical Sciences Vol. 7, No. 1, (June 2011) : 45-50 AN ORDINARY DIFFERENTIAL EQUATION MODEL OF DIABETIC POPULATION IN NEW DELHI Sandhya, Deepak Kumar & Prerna Pandit
More informationChapter 37: Exercise Prescription in Patients with Diabetes
Chapter 37: Exercise Prescription in Patients with Diabetes American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationTraining Your Caregiver: Diabetes
Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate,
More informationAgasthiar siddha Diabetes Research Centre. Welcome to our Health Care
1 Agasthiar siddha Diabetes Research Centre Welcome to our Health Care Diabetes Mellitus is a metabolic disorder characterized by hyperglycemia due to absolute or relative deficiency of insulin. Traditional
More informationAssessment and occurrence of adverse effects after the consumption of Siddha drugs
INTERNATIONAL JOURNAL OF CURRENT RESEARCH IN CHEMISTRY AND PHARMACEUTICAL SCIENCES (p-issn: 2348-5213: e-issn: 2348-5221) www.ijcrcps.com DOI: 10.22192/ijcrcps Coden: IJCROO(USA) Volume 6, Issue 4-2019
More informationAvailable Online through Research Article
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com STANDARDIZATION OF SIDDHA DRUG SANGU PARPAM USING INFRARED SPECTRUM V.N. Meena devi * 1 P. Nagendra Prasad 2 & K. Kalirajan
More informationSLEEP IN THE FACE OF CANCER AND DIABETES
SLEEP IN THE FACE OF CANCER AND DIABETES Joseph Anderson, CCSH, RPSGT, RST, RPFT, CRT-NPS Certified Clinical Sleep Health Educator Supervisor, Integrated Sleep Disorders Center & Tele-Sleep Coordinator
More informationAwareness of Diabetic Retinopathy in Rural Population in South Tamil Nadu
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/336 Awareness of Diabetic Retinopathy in Rural Population in South Tamil Nadu N Sharmila 1, K Kavitha 1, S Ganapathy
More informationLecture. By Dr Ale A.O Lecturer. Consultant Physician/Endocrinologist.
Lecture By Dr Ale A.O Lecturer. Consultant Physician/Endocrinologist. DIABETES MELLITUS A GLOBAL EMERGENCY 2015 DIABETES MELLITUS Diabetes is one of the largest global health emergencies of the 21 st century.
More informationEFFECT OF JAMUN SEED POWDER SUPPLEMENTATION ON THE BODY MASS INDEX AND FASTING PLASMA GLUCOSE LEVELS IN WOMEN WITH TYPE 2 DIABETES MELLITUS
EFFECT OF JAMUN SEED POWDER SUPPLEMENTATION ON THE BODY MASS INDEX AND FASTING PLASMA GLUCOSE LEVELS IN WOMEN WITH TYPE 2 DIABETES MELLITUS Sheba Jeyaraj Assistant Professor, Finy Susan Research Scholar,
More informationAn Overview Of Diabetes And Endocrinology.
An Overview Of Diabetes And Endocrinology. Maraveyas Anthony Maraveyas Anthony Department of Academic Oncology Castle Hill Hospital England UK Tel: 01482461318 Research interests Diabetes Endocrinology.
More informationIJBCP International Journal of Basic & Clinical Pharmacology
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20164105 Original Research Article Assessment of
More informationResearch Article International Ayurvedic Medical Journal ISSN: JIAR, Jammu, India ABSTRACT
Research Article International Ayurvedic Medical Journal ISSN:2320 5091 ROLE OF SHILAJIT IN THE MANAGEMENT OF MADHUMEHA w.s.r. to DIABETES MELLITUS Trivedi Atal Bihari 1, Mahajan Nitin 2, Mahajan Nikhil
More informationDiabetes in the Real World
Diabetes in the Real World Diabetes Mellitus Common hormonal disorder of dogs and cats due to insufficient insulin being produced or cells not being able to respond to insulin Results in hyperglycaemia
More informationCharacterization of the Traditional Siddha medicine Vengara parpam through spectroscopic analysis. T. Maduravani * and M.
IP Indexing - Impact factor 3.5 Volume: 3; Issue: 6; June-2017; pp 1261-1265. ISSN: 2454-5422 Characterization of the Traditional Siddha medicine Vengara parpam through spectroscopic analysis T. Maduravani
More informationCOMPARATIVE STUDY ON DUAL AND TRIPLE THERAPY USING ORAL ANTIDIABETIC DRUGS IN TREATMENT OF TYPE 2 DIABETES MELLITUS
COMPARATIVE STUDY ON DUAL AND TRIPLE THERAPY USING ORAL ANTIDIABETIC DRUGS IN TREATMENT OF TYPE 2 DIABETES MELLITUS Shakya Sangita 1, Bajracharya Smrity, Shakya Amit, Shakya Santosh, Chaudhary Shailendra,
More informationLocal Anesthesia for Dental Hygienists Session III. Altered Consciousness and Diabetes Michael E. O Brien, DDS and Frank S.
Altered Consciousness in General Dr. Michael E. O Brien Dr. Frank S. Drongowski Definitions Confusion - a mental state marked by disturbances in comprehension, understanding, and resulting in bewilderment
More informationScreening for diabetes
Screening for diabetes Peggy Odegard, Pharm.D, BCPS, CDE What are your risks? 1 Diabetes Mellitus A problem with glucose regulation type 1= pancreas cannot produce insulin so total insulin deficiency,
More informationProfile of diabetes mellitus in elderly of Chandigarh, India. S Puri, M Kalia, H Swami, A Singh, Abhimanyu, C Mangat, A Kaur, S Kaur
ISPUB.COM The Internet Journal of Endocrinology Volume 4 Number 1 S Puri, M Kalia, H Swami, A Singh, Abhimanyu, C Mangat, A Kaur, S Kaur Citation S Puri, M Kalia, H Swami, A Singh, Abhimanyu, C Mangat,
More informationSudha Revathy Sudarsanam et al / Int. J. Res. Ayurveda Pharm. 5(4), Jul - Aug Research Article.
Research Article www.ijrap.net PROCESS STANDARDISATION OF KARA SOODA SATHU PARPAM: A SIDDHA HERBO MINERAL DRUG Sudha Revathy Sudarsanam 1 *, Murugesan Moonandi 2 1 Ph.D Scholar, National Institute of Siddha,
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 211, 3(4): 684-696 Prevelance of diabetes in Vellore district,
More informationEffect of Supplementation of Tulsi Leaves or Curry Leaves or Combination of both Type 2 Diabetes
Available online at www.ijpab.com INTERNATIONAL JOURNAL OF PURE & APPLIED BIOSCIENCE ISSN: 2320 7051 Int. J. Pure App. Biosci. 3 (2): 331-337 (2015) Research Article Effect of Supplementation of Tulsi
More informationFocus on diabetes mellitus - A review. Saravanan K * and Manna PK. Department of pharmacy, Annamalai university, Annamalai Nagar, Tamilnadu, India
International Journal of Chemical and Pharmaceutical Sciences 2014, Dec., Vol. 5 (4) ISSN: 0976-9390 IJCPS Focus on diabetes mellitus - A review Saravanan K * and Manna PK. Department of pharmacy, Annamalai
More information1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown
Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 17 Caring for Clients with Diabetes Mellitus Diabetes Mellitus Chronic disease Not a single disorder
More information1) There is an emerging global epidemic of diabetes that can be traced back to rapid increases in overweight, obesity and physical inactivity
WHAT IS DIABETES? Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. Hyperglycaemia, or raised
More informationDiabetes, sugar. Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA (724)
Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA 16125 (724) 588-5260 Feline diabetes mellitus Diabetes, sugar AffectedAnimals: Most diabetic cats are older than 10 years of age when
More informationPATIENT LEAFLET TYPE 2 DIABETES MELLITUS
PATIENT LEAFLET TYPE 2 DIABETES MELLITUS ASSOCIATION OF COMMUNITY PHARMACIST OF INDIA ROLE OF PHARMACIST IN DISEASE MANAGMENT: Type 2 Diabetes Mellitus DIET Diet: No fats, sugars, red meat and dairy products
More informationEFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY
Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines
More informationDiabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel
Diabetes Review October 31, 2012 Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review Learning Objectives: Describe the anatomy and physiology of the pancreas Describe the effects of hormones on the maintenance
More informationMetformin Hydrochloride
Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin
More informationEffect of Amla Powder and Turmeric Powder Consumption on Middle Aged (40-59 Years) Non-Insulin Dependent Diabetics
Available online at www.ijpab.com Yadav et al Int. J. Pure App. Biosci. 6 (3): 70-76 (2018) ISSN: 2320 7051 DOI: http://dx.doi.org/10.18782/2320-7051.6438 ISSN: 2320 7051 Int. J. Pure App. Biosci. 6 (3):
More informationResearch Article ISSN Vol 2/Issue 3/Jul-Sept 2012 *G. SOMASUNDARAM, K. MANIMEKALAI, KARTIK J. SALWE AND J. PANDIAMUNIAN.
EVALUATION OF THE ANTIDIABETIC EFFECT OF OCIMUM SANCTUM IN TYPE 2 DIABETIC PATIENTS. *G. SOMASUNDARAM, K. MANIMEKALAI, KARTIK J. SALWE AND J. PANDIAMUNIAN. Department of, Mahatma Gandhi Medical College
More informationMonitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse
Monitoring in Type 2 Diabetes Senga Hunter Community Diabetes Specialist Nurse Learning Outcomes Understand why blood monitoring is necessary Understand the blood tests for monitoring diabetes Understand
More informationAnalysis of drug used for the treatment of complications of diabetes in a teaching hospital
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011: 3 (4)163-177 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationATHLETES & PRESCRIBING PHYSICIANS PLEASE READ
ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ USADA can grant a Therapeutic Use Exemption (TUE) in compliance with the World Anti- Doping Agency International Standard for TUEs. The TUE application process
More informationANTIDIABETIC ACTIVITY OF KOVAI KIZHANGU CHOORANAM IN ALLOXAN INDUCED DIABETIC RATS ABSTRACT
ANTIDIABETIC ACTIVITY OF KOVAI KIZHANGU CHOORANAM IN ALLOXAN INDUCED DIABETIC RATS P. PARTHIBAN 1, RAVIKUMAR 1, J. ANBU *2 AND ASHWINI ANJANA 2 1 Department of Medicine, Govt. Siddha College, Arumbakkam,
More informationScreening of Type II Diabetes Mellitus on the Basis of IDRS Among Urban Population of Bhopal, Madhya Pradesh
Short Article Screening of Type II Diabetes Mellitus on the Basis of IDRS Among Urban Population of Bhopal, Madhya Pradesh Jyoti Markam 1 Date of Submission: 21.12.214 Date of Acceptance: 31.12.214 Abstract
More informationDIABETES AND RAMADAN FASTING
DIABETES AND RAMADAN FASTING Dr. A. Nigam, M.B.B.S., M.D. (Medicine) Specialist Internal Medicine Al Zahrawi Hospital, Ras Al Khaimah, U.A.E. It is estimated that UAE s population currently stands at approximately
More informationSerum uric acid levels and its association with type 2 diabetes mellitus. Received: / Revised Accepted: / Published:
World Journal of Pharmaceutical Sciences ISS (Print): 2321-3310; ISS (Online): 2321-3086 Available online at: http://www.wjpsonline.org/ Original Article Serum uric acid levels and its association with
More informationPre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis
Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis Exceptional healthcare, personally delivered 2 This leaflet is for patients with Type 2 diabetes who require insulin
More informationLowers Blood Sugar Naturally
Lowers Blood Sugar Naturally Scientific Studies Have Proven That These Eleven Natural Ingradients Normalise Blood Sugar Momordica charantia Gymnema sylvestre Pterocarpus marsupium Salacia Reticulata Curcuma
More informationThe World Health Organization (WHO) has described diabetes mellitus as Metabolic
1.1. Background The World Health Organization (WHO) has described diabetes mellitus as Metabolic disorder of multiple etiology characterized by chronic hyperglycemia with disturbances of carbohydrate,
More informationInternational Journal of Current Biotechnology
Chelliah Bala Sankar and Abraham Muthukumar, The Effect of the Removal of Renal Stone using a Siddha Medicine Protocol, Int.J.Curr.Biotechnol., 2014, 2(5):1-5. International Journal of Current Biotechnology
More informationPage # 1. Objectives. History of Clinical Trials. Developing New Therapies Clinical Studies and Trials. FDA Classification of Clinical Studies/Trials
Developing New Therapies Clinical Studies and Trials Richard C. Eastman M.D. Objectives Discuss how new treatments are studied in humans. Explain how the rights of human volunteers are safeguarded. Discuss
More informationSTUDY ON ACUTE TOXICITY OF SIDDHA FORMULATION UPPU CHENDURAM - II IN WISTAR RATS
Siddha Papers 2018 (13) (2) RESEARCH ARTICLE https://www.siddhapapers.com STUDY ON ACUTE TOXICITY OF SIDDHA FORMULATION UPPU CHENDURAM - II IN WISTAR RATS Bhuvaneshwari T* 1, Subash Chandran G 2, Manoharan
More informationPrevalence of Diabetes and Associated Risk Factors among Selected Type 2 Diabetes
Prevalence of Diabetes and Associated Risk Factors among Selected Type 2 Diabetes V. Kavitha 1, V. Saradha Ramadas 2 1 Assistant professor, Department of Nutrition and Dietetics, Jamal Mohamed College
More informationThe Battle against Non-communicable Diseases can be won IA.. Lidia Belkis Archbold Health Ministries - IAD
The Battle against Non-communicable Diseases can be won IA.. Lidia Belkis Archbold Health Ministries - IAD Non-communicable diseases (NCDs), also known as chronic diseases are not transmitted from person
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Prednicare Tablets 1 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION mg per tablet Active: Prednisolone 1.0 Other ingredients:
More informationAdepu and Adusumilli: Drug-related Problems in Patients with Chronic Diseases in South India
Assessment of Drug-related Problems in Patients with Chronic Diseases through Health Status Survey in a South Indian Rural Community Setting R. ADEPU* AND P. K. ADUSUMILLI Department of Pharmacy Practice,
More informationTUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS
DIABETES MELLITUS 1. Introduction Diabetes is a global epidemic with 415 million people affected worldwide equivalent to the total population of the USA, Canada and Mexico. In recognition of this, the
More informationStudy of significance of glycosylated hemoglobin in diabetic patient
Original Research Article Study of significance of glycosylated hemoglobin in diabetic patient Dimpal Modi 1*, Gunvanti B. Rathod 2, K. N. Delwadia 3, H. M. Goswami 4 1 Tutor, Pathology Department, GMERS
More informationDiabetes mellitus is when the pancreas (a gland near the stomach) does not produce enough insulin to properly regulate blood glucose levels.
DIABETES MELLITUS What is Diabetes Mellitus? Level 1, 26 Robertson St Kensington 3031 VIC Australia T (03) 9092 0400 F (03) 9376 8567 info@advancedvetcare.com.au... ABN 29 814 586 915 Diabetes mellitus
More informationMANAGEMENT OF TYPE 1 DIABETES MELLITUS
MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationA Study on Ayurveda Poly Herbal Compound of Yogaratnakar (17 - A.D.) w.s.r. Rakta-Pradara (Abnormal Uterine Bleeding)
International Journal of Ayurvedic Medicine, 2012, 3(4), 222-231 A Study on Ayurveda Poly Herbal Compound of Yogaratnakar (17 - A.D.) w.s.r. Rakta-Pradara (Abnormal Uterine ) Research Article Nomina V
More informationCAUSES AND CONSEQUENCES
What Is Diabetes CAUSES AND CONSEQUENCES Che cos è il diabete What Is Diabetes DIABETES MELLITUS is a frequent lifelong disease. In Italy there are 3.5 million people with diabetes, plus nearly 1.5 million
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe
More informationJournal of Advanced Scientific Research
Prabhu et al, J Adv Sci Res, 2013, 4(1): 38-42 38 Journal of Advanced Scientific Research Available online through http://www.sciensage.info/jasr ISSN 0976-9595 Research Article Awareness on Type II Diabetes
More informationClinical Care Performance. Financial Year 2012 to 2018
Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c
More informationJMSCR Vol 06 Issue 10 Page October 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i10.44 Original Research Article Evaluation
More informationInternational Journal of Research in Pharmacology & Pharmacotherapeutics
International Journal of Research in Pharmacology & Pharmacotherapeutics ISSN Print: 2278-2648 IJRPP Vol.3 Issue 4 Oct-Dec-2014 ISSN Online: 2278-2656 Journal Home page: Research article Open Access Anti-diabetic
More informationGlycemic Control in Type 2 Diabetes Mellitus Patients
Chattagram Maa-O-Shishu Hospital Medical College Journal DOI: 10.11566/cmosh.2013.1201.4 Original Article Glycemic Control in Type 2 Diabetes Mellitus Patients Siddiqui SRA 1 Rahman MZ 2 * Alam ASMT 1
More information1. PATHOPHYSIOLOGY OF DIABETES MELLITUS
1. PATHOPHYSIOLOGY OF DIABETES MELLITUS Prof. Vladimir Palicka, M.D., Ph.D. Institute for Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic Diabetes mellitus is
More informationDiabetes and Kidney Disease: Time to Act. Your Guide to Diabetes and Kidney Disease
Diabetes and Kidney Disease: Time to Act Your Guide to Diabetes and Kidney Disease Diabetes is fast becoming a world epidemic Diabetes is reaching epidemic proportions worldwide. Every year more people
More informationInsulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction
More informationMedical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition
Medical Nutrition Therapy for Diabetes Mellitus Raziyeh Shenavar MSc. of Nutrition Diabetes Mellitus A group of diseases characterized by high blood glucose concentrations resulting from defects in insulin
More informationDiabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood.
1 of 15 12/30/2012 10:52 PM PubMed Health. A service of the National Library of Medicine, National Institutes of Health. A.D.A.M. Medical Encyclopedia. Atlanta (GA): A.D.A.M.; 2011. Diabetes Last reviewed:
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationIndian J. Prev. Soc. Med. Vol. 45 No. 1-2, 2014
ISSN- 0301-1216 Indian J. Prev. Soc. Med. Vol. 45 No. 1-2, 2014 EFFECT OF SOCIAL FACTORS ON GLYCEMIC CONTROL OF PATIENT WITH DIABETES MELLITUS Mousumi Bhattacharya, 1 Shashi Rani Agrawal, 2 Saurabh Singh,
More informationHEAVY METAL ANALYSIS OF IRU NELLI KARPAM A SIDDHA MEDICINE FOR SKIN DISORDERS.
HEAVY METAL ANALYSIS OF IRU NELLI KARPAM A SIDDHA MEDICINE FOR SKIN DISORDERS. Thomas M. Walter*, N. S. Priya Devi, S. Thanalakshmi, S. Merish, M. Sathya Govt. Siddha Medical College, Palayamkottai, Tamilnadu.
More informationThe DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN
1. INTRODUCTION The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN 2014 2018 UNITE AGAINST DIABETES STOP RISING TREND Diabetes is a significant and growing challenge globally that affects individuals,
More informationRISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY
Health and Population - Perspectives and Issues 37 (1 & 2), 40-49, 2014 RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY FuJun Wang*, V. K. Tiwari** and Hao Wang*** ABSTRACT To identify
More informationType I diabetes mellitus. Dr Laurence Lacroix
mellitus Dr Laurence Lacroix 26.03.2014 1 DEFINITION: Group of diseases characterized by a disorder of glucose homeostasis with high levels of blood glucose resulting from defects in : o insulin production
More informationChapter 14 Elderly, Home and Long-term Care Collections. Objectives:
EXERCISE 11: BEDSIDE GLUCOSE TESTING Textbook: Skills: Chapter 14 Elderly, Home and Long-term Care Collections 15 points Objectives: 1. Define diabetes mellitus. 2. Compare and contrast: Type 1 Diabetes,
More informationDiabetes Mellitus and the Dental Healthcare Professional
Diabetes Mellitus and the Dental Healthcare Professional Jerry A. Brown DMD, CDE University of South Florida Department of Internal Medicine jabrown7@health.usf.edu Learning Objectives Diabetes- The Disease
More informationFebruary/March Diabetes - the Medical Perspective
February/March 2006 In every issue: < Diabetes - the Medical Perspective < Diabetes and Food < Exercise as a Part of Living < Recipes to Try < Medication Update < New resources Events Diabetes - the Medical
More informationEstimation of Blood Glucose level. Friday, March 7, 14
Estimation of Blood Glucose level Importance Diagnosis and treatment of carbohydrate metabolism disorders Monitor the effectivity and response to an ongoing treatment procedure Control mechanism Insulin
More informationDiabetes Mellitus Case Study
COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the
More informationInternational Journal of Allied Medical Sciences and Clinical Research (IJAMSCR)
International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR) IJAMSCR Volume 3 Issue 1 Jan-Mar- 2015 www.ijamscr.com Research article Medical research Diabetes mellitus associated mortality:
More informationHypoglycemic Activity of Seerankottai Thiravam (Semicarpus Anacardium. Linn) in Alloxan Induced Diabetic Rats
Research Article Hypoglycemic Activity of Seerankottai Thiravam (Semicarpus Anacardium. Linn) in Alloxan Induced Diabetic Rats P. Parthiban 1, K. Kanagavalli 1, P. Sathiya Rajeswaran 2, J. Anbu 3, A. Chinnasamy
More information1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003
1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003 Report The diabetes prevention and control programme of the Islamic Republic of Iran F. Azizi, 1 M.M. Gouya, 2 P. Vazirian, 2
More information